445 related articles for article (PubMed ID: 19962941)
1. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
Inoue Y; Hirata K; Kuroda K; Fujita M; Shimizu T; Emura N; Uchimura N; Kagimura T; Sha K; Nozawa T
Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.
Partinen M; Hirvonen K; Jama L; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2006 Aug; 7(5):407-17. PubMed ID: 16815748
[TBL] [Abstract][Full Text] [Related]
3. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
[TBL] [Abstract][Full Text] [Related]
4. Long-term open-label study of pramipexole in patients with primary restless legs syndrome.
Inoue Y; Kuroda K; Hirata K; Uchimura N; Kagimura T; Shimizu T
J Neurol Sci; 2010 Jul; 294(1-2):62-6. PubMed ID: 20451927
[TBL] [Abstract][Full Text] [Related]
5. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.
Ferini-Strambi L; Aarskog D; Partinen M; Chaudhuri KR; Sohr M; Verri D; Albrecht S
Sleep Med; 2008 Dec; 9(8):874-81. PubMed ID: 18952497
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study).
Oertel WH; Stiasny-Kolster K; Bergtholdt B; Hallström Y; Albo J; Leissner L; Schindler T; Koester J; Reess J;
Mov Disord; 2007 Jan; 22(2):213-9. PubMed ID: 17133582
[TBL] [Abstract][Full Text] [Related]
7. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
Saletu M; Anderer P; Saletu-Zyhlarz G; Hauer C; Saletu B
Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):185-94. PubMed ID: 12242580
[TBL] [Abstract][Full Text] [Related]
8. Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study).
Partinen M; Hirvonen K; Jama L; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2008 Jul; 9(5):537-41. PubMed ID: 18276187
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: results from a multi-center, randomized, double-blind, placebo-controlled trial.
Ma JF; Wan Q; Hu XY; Sun SG; Wang WZ; Zhao ZX; Wang YJ; Liu CF; Li JM; Jiang YP; Chen SD
Sleep Med; 2012 Jan; 13(1):58-63. PubMed ID: 22137119
[TBL] [Abstract][Full Text] [Related]
10. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
Manconi M; Ferri R; Zucconi M; Oldani A; Fantini ML; Castronovo V; Ferini-Strambi L
Sleep Med; 2007 Aug; 8(5):491-7. PubMed ID: 17512780
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of sumanirole in restless legs syndrome: a phase II, randomized, double-blind, placebo-controlled, dose-response study.
Garcia-Borreguero D; Winkelman J; Adams A; Ellis A; Morris M; Lamb J; Layton G; Versavel M;
Sleep Med; 2007 Mar; 8(2):119-27. PubMed ID: 17239657
[TBL] [Abstract][Full Text] [Related]
12. Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome.
Trenkwalder C; Stiasny-Kolster K; Kupsch A; Oertel WH; Koester J; Reess J
Mov Disord; 2006 Sep; 21(9):1404-10. PubMed ID: 16755554
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome.
Quilici S; Abrams KR; Nicolas A; Martin M; Petit C; Lleu PL; Finnern HW
Sleep Med; 2008 Oct; 9(7):715-26. PubMed ID: 18226947
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K
Neurology; 2006 Sep; 67(6):1040-6. PubMed ID: 16931508
[TBL] [Abstract][Full Text] [Related]
15. Relationship of periodic leg movements and severity of restless legs syndrome: a study in unmedicated and medicated patients.
Hornyak M; Hundemer HP; Quail D; Riemann D; Voderholzer U; Trenkwalder C
Clin Neurophysiol; 2007 Jul; 118(7):1532-7. PubMed ID: 17531532
[TBL] [Abstract][Full Text] [Related]
16. Correlation between putative indicators of primary restless legs syndrome severity.
Aksu M; Demirci S; Bara-Jimenez W
Sleep Med; 2007 Jan; 8(1):84-9. PubMed ID: 16740410
[TBL] [Abstract][Full Text] [Related]
17. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
Walters AS; Ondo WG; Dreykluft T; Grunstein R; Lee D; Sethi K;
Mov Disord; 2004 Dec; 19(12):1414-23. PubMed ID: 15390050
[TBL] [Abstract][Full Text] [Related]
18. Comparison of pregabalin with pramipexole for restless legs syndrome.
Allen RP; Chen C; Garcia-Borreguero D; Polo O; DuBrava S; Miceli J; Knapp L; Winkelman JW
N Engl J Med; 2014 Feb; 370(7):621-31. PubMed ID: 24521108
[TBL] [Abstract][Full Text] [Related]
19. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
[TBL] [Abstract][Full Text] [Related]
20. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.
Garcia-Borreguero D; Larrosa O; Williams AM; Albares J; Pascual M; Palacios JC; Fernandez C
Neurology; 2010 Jun; 74(23):1897-904. PubMed ID: 20427750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
